BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16306803)

  • 1. Divergent action of calcium channel blockers on ATP-binding cassette protein expression.
    Hasegawa K; Wakino S; Kanda T; Yoshioka K; Tatematsu S; Homma K; Takamatsu I; Sugano N; Hayashi K
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):787-93. PubMed ID: 16306803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
    Ikeda K; Saito T; Tojo K
    Tohoku J Exp Med; 2011 Aug; 224(4):263-71. PubMed ID: 21757861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
    Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of efonidipine hydrochloride on cholesterol esterification mediated by beta-very low density lipoprotein in J774 macrophages.
    Kitahara M; Toyoda K; Yamashita T; Sakashita M; Tanaka S; Saito Y
    Jpn J Pharmacol; 1995 Oct; 69(2):101-9. PubMed ID: 8569046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
    Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
    Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for efonidipine block of a voltage-gated Ca
    Xu F; Xiong W; Huang Y; Shen J; Zhou D; Tang L
    Biochem Biophys Res Commun; 2019 Jun; 513(3):631-634. PubMed ID: 30981510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
    Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF
    Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism.
    Suzuki S; Nishimaki-Mogami T; Tamehiro N; Inoue K; Arakawa R; Abe-Dohmae S; Tanaka AR; Ueda K; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):519-25. PubMed ID: 14726413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
    Lei B; Hitomi H; Mori T; Nagai Y; Deguchi K; Mori H; Masaki T; Nakano D; Kobori H; Kitaura Y; Nishiyama A
    J Pharmacol Sci; 2011; 117(2):98-105. PubMed ID: 21897055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aranidipine, a novel calcium channel blocker, on mechanical responses of the isolated rat portal vein: comparison with typical calcium channel blockers and potassium channel openers.
    Okumura K; Ichihara K; Nagasaka M
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):209-15. PubMed ID: 9057070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells.
    Hayashi M; Yamaji Y; Nakazato Y; Saruta T
    Hypertens Res; 2000 Sep; 23(5):521-5. PubMed ID: 11016808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
    Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
    Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ca(2+) channel inhibitor efonidipine decreases voltage-dependent K(+) channel activity in rabbit coronary arterial smooth muscle cells.
    Park MH; Son YK; Hong DH; Choi IW; Kim DJ; Lee H; Bang H; Na SH; Li H; Jo SH; Park WS
    Vascul Pharmacol; 2013; 59(3-4):90-5. PubMed ID: 23876554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
    Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.